BCAB
Price:
$3.86
Market Cap:
$4.87M
BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sarcoma, non-small cell lung cancer (NSCLC), and ovarian cancer. Additionally, BioAtla is advancing BA3021, another CAB ADC, for a variety of solid malignancies such as NSCLC, melanoma, and ovarian cancer. A third candidate, BA3071, is a conditionally active anti-cytotoxic T-lymphocyte-associated antigen...[Read more]
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
NASDAQ
Ticker
BCAB
According to BioAtla, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.00M. This represents a change of -63.25% compared to the average of 24.49M of the last 4 quarters.
The mean historical Enterprise Value of BioAtla, Inc. over the last ten years is 401.18M. The current 9.00M Enterprise Value has changed 124.35% with respect to the historical average. Over the past ten years (40 quarters), BCAB's Enterprise Value was at its highest in in the March 2021 quarter at 1.49B. The Enterprise Value was at its lowest in in the June 2022 quarter at -90936002.50.
Average
401.18M
Median
274.23M
Minimum
-19493435.48
Maximum
1.06B
Discovering the peaks and valleys of BioAtla, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.11%
Maximum Annual Enterprise Value = 1.06B
Minimum Annual Increase = -328.75%
Minimum Annual Enterprise Value = -19493435.48
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 32.48M | -266.64% |
| 2024 | -19493435.48 | -328.75% |
| 2023 | 8.52M | -92.23% |
| 2022 | 109.62M | -75.02% |
| 2021 | 438.83M | -51.62% |
| 2020 | 906.98M | -14.33% |
| 2019 | 1.06B | 57.11% |
The current Enterprise Value of BioAtla, Inc. (BCAB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.17M
5-year avg
113.99M
10-year avg
401.18M
BioAtla, Inc.’s Enterprise Value is less than Celularity Inc. (51.87M), less than PolyPid Ltd. (40.34M), less than Annovis Bio, Inc. (20.80M), greater than Reviva Pharmaceuticals Holdings, Inc. (-19627463.00), greater than Evaxion Biotech A/S (7.26M), less than BioXcel Therapeutics, Inc. (118.31M), greater than Mural Oncology plc (-19941249.00), less than Generation Bio Co. (40.14M), less than Veru Inc. (23.39M), less than Mersana Therapeutics, Inc. (91.27M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 51.87M | $17.15M | |
| 40.34M | $47.08M | |
| 20.80M | $35.02M | |
| -19627463.00 | $2.33M | |
| 7.26M | $22.99M | |
| 118.31M | $35.20M | |
| -19941249.00 | $35.38M | |
| 40.14M | $35.98M | |
| 23.39M | $48.15M | |
| 91.27M | $145.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioAtla, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioAtla, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioAtla, Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioAtla, Inc. (BCAB)?
What is the 3-year average Enterprise Value for BioAtla, Inc. (BCAB)?
What is the 5-year average Enterprise Value for BioAtla, Inc. (BCAB)?
How does the current Enterprise Value for BioAtla, Inc. (BCAB) compare to its historical average?